MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

77 hedge funds and large institutions have $307M invested in Marinus Pharmaceuticals, Inc in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 20 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
-17
Holders Change %
-18.09%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
11
Increased
39
Reduced
20
Closed
28
Calls
$23.2M
Puts
$12.1M
Net Calls
+$11.1M
Net Calls Change
+$11.7M

Top Buyers

1
6CM
1
683 Capital Management
New York
$12.5M
2
MS
2
Maven Securities
Jersey
$6.89M
3
BlackRock
3
BlackRock
New York
$22.5M
4
SCM
4
Suvretta Capital Management
New York
$10M
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$12M

Top Sellers

1
VA
1
VR Adviser
New York
$15.3M
2
WG
2
Winton Group
United Kingdom
$0
3
MIM
3
Monashee Investment Management
Massachusetts
$0
4
Two Sigma Investments
4
Two Sigma Investments
New York
$209K
5
ACM
5
Asymmetry Capital Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Ameriprise
101
Ameriprise
Minnesota
– -$26K -2,550 Closed
PAG
102
Private Advisor Group
New Jersey
– -$25K -2,500 Closed
BNP Paribas Financial Markets
103
BNP Paribas Financial Markets
France
– -$15.7K -1,546 Closed
VFA
104
Valeo Financial Advisors
Indiana
– -$4K -375 Closed
CAPTRUST Financial Advisors
105
CAPTRUST Financial Advisors
North Carolina
– -$1K -125 Closed
1 2 3 4
5